OTTAWA, Nov. 16, 2011 /CNW/ - Canada's Research-Based Pharmaceutical
Companies (Rx&D) is pleased to announce the appointment of Philip
Blake, President and Chief Executive Officer (CEO) of Bayer Inc., as
Chairman of the Board of Directors for 2011 - 2012. Mr. Blake assumed
the Board chairmanship during today's Rx&D Annual General meeting held
Mr. Blake is a member of Rx&D's Executive Committee and Board of
Directors. Until becoming Board Chairman, he fulfilled the roles of
First Vice-Chair, Board of Directors; Chair, of the Atlantic Committee;
Member of the Membership Committee, By-Laws Committee, Nominating
Committee & HR Committee. Mr. Blake was first elected in 2000 and
became a member of Executive Committee in 2003. He served as Chair of
the association in 2007. He was re-elected in 2008 for a full
three-year term to the Rx&D Board.
"The research-based pharmaceutical industry makes an important
contribution to the quality of life of all Canadians by discovering and
developing the new medicines vaccines and biologics that have allowed
us to live longer and in better health. I am very honoured to once
again lead the Rx&D Board", says Mr. Blake.
"Canadians will continue to benefit from the research-based
pharmaceutical industry's role as a leader in R&D and innovation as we
search for life-saving treatments. We never forget that patients are at
the heart of our drive for innovative medicines."
Philip Blake is President & CEO, Bayer Inc. and Head of Bayer HealthCare
in Canada. Under his leadership, the organization has become one of the
country's top five healthcare companies, and has been named one of
Canada's Top 100 Employers for the past 5 years running as well as one
of Canada's Greenest Employers for the past 3 years. Bayer is
headquartered in Toronto and Calgary, employing approximately 1100
professionals from coast to coast.
Mr. Blake was appointed President & CEO of Bayer Inc. in 2002. In his 30
year career with Bayer, Mr. Blake has held leadership positions around
the world focusing on global strategic product marketing, business
development, clinical planning, product developments and sales
management. He was also responsible for the successful integration of a
major Canadian pharmaceuticals company into Bayer's pharmaceutical
business in Canada.
In 2006, Mr. Blake was inducted into the Canadian Pharmaceutical
Marketing Hall of Fame and in 2008 was named Communicator of the Year
by the International Association of Business Communicators (IABC).
Rx&D is the association of leading research-based pharmaceutical
companies dedicated to improving the health of Canadians through the
discovery and development of new medicines and vaccines. Our community
represents 15,000 men and women working for 50 member companies and
invests more than $1 billion in research and development each year to
fuel Canada's knowledge-based economy. Guided by our Code of Ethical
Practices, our membership is committed to working in partnership with
governments, healthcare professionals and stakeholders in a highly
SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX
For further information: